Scientific World Model

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

Showing 1–10 of 10 pages matching "glp-1"

💊 GLP-1 Receptor Agonists in NeurodegenerationKG

therapeutic · 2,720 words · 279 hyp54 ana66 exp

💊 GLP-1 Receptor Agonists for Parkinson's DiseaseKG

therapeutic · 2,682 words · 23 hyp24 ana75 exp

💊 section-209-glp-1-receptor-agonists-cbs-pspKG

therapeutic · 2,422 words · 16 hyp9 ana24 exp

💊 Tirzepatide and Dual GIP/GLP-1 Agonists for NeurodegenerationKG

therapeutic · 2,057 words · 285 hyp53 ana70 exp

💊 GLP-1 Receptor Agonists for NeurodegenerationKG

therapeutic · 1,708 words · 282 hyp43 ana65 exp

💊 GLP-1 Receptor Agonists for Neurodegenerative DiseasesKG

therapeutic · 1,525 words · 142 hyp61 ana19 exp

💊 GIP/GLP-1 Dual Agonists for Neurodegenerative DiseasesKG

therapeutic · 1,424 words · 143 hyp60 ana6 exp

💊 GLP-1 Receptor Agonists for Neurodegenerative DiseasesKG

therapeutic · 1,073 words · 145 hyp60 ana13 exp

💊 GLP-1 and GIP Agonists for NeurodegenerationKG

therapeutic · 935 words · 281 hyp53 ana65 exp

💊 Triple Incretin Agonists (GLP-1/GIP/Glucagon) for NeurodegenerationKG

therapeutic · 741 words · 281 hyp54 ana57 exp